<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Q218 Trauma Market Recap: Healthy Growth, Slight Slowdown

9/5/18 9:19 AM

Q218 Trauma Market RecapUS market experiences slight softening as the top four trauma players all post sequential declines in Q218

The WW Trauma Market was up in Q218 – the third consecutive quarter of growth in the +4% range. Internationally, positive sales growth in Europe offset a sequential slowdown in Rest of World (ROW). In Europe, revenues were steady, while ROW sales dipped sequentially as the top players reported softer growth due to tough comps as a result of 2017 tender orders...

Among the many topics covered Q218 Trauma Market Recap are:

  • Top Players Post Slight Sequential Downturns
  • New Players Experience Delays
  • IM Nailing Soars Due to Existing Products along with New Intros
  • Trauma Regulatory Highlights

The top four trauma players all posted slight sequential declines in Q218. DePuy Synthes cited pricing pressure, while Smith & Nephew attributed their downturn to a 2017 Middle East tender order, indicating...

Read entire Q218 US Trauma Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

Topics: Orthopedics

Natasha Weeks
Written by Natasha Weeks

13 years' experience in marketing and product development, including 5+ years at DePuy Synthes Trauma - most recently as Product Director at DePuy Synthes Trauma.

    Recent Articles